Lexicon Pharmaceuticals
LXRX
#7418
Rank
S$0.55 B
Marketcap
S$1.52
Share price
2.61%
Change (1 day)
64.57%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -S$92.22 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are S$70.86 Million. In 2024 the company made an earning of -S$0.26 Billion a decrease over its 2023 earnings that were of -S$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$92.22 Million-64.39%
2024 -S$0.26 Billion13.15%
2023 -S$0.23 Billion73.74%
2022 -S$0.14 Billion16.16%
2021 -S$0.12 Billion49.82%
2020 -S$75.7 Million-147.19%
2019 S$0.16 B-203.42%
2018 -S$0.16 Billion-15.31%
2017 -S$0.19 Billion0.2%
2016 -S$0.19 Billion2920.7%
2015 -S$6.06 Million-95.33%
2014 -S$0.13 Billion-3.61%
2013 -S$0.14 Billion-5.52%
2012 -S$0.15 Billion-4.17%
2011 -S$0.15 Billion15.5%
2010 -S$0.13 Billion8.36%
2009 -S$0.12 Billion-4.81%
2008 -S$0.13 Billion28.79%
2007 -S$96.87 Million35.71%
2006 -S$71.38 Million52.91%
2005 -S$46.68 Million-23.89%
2004 -S$61.33 Million-24.19%
2003 -S$80.89 Million-0.48%
2002 -S$81.28 Million44.12%
2001 -S$56.4 Million23.01%
2000 -S$45.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eterna Therapeutics
ERNA
-S$12.27 Million-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$6.64 B-7,602.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-S$0.68 Billion 656.31%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.87 B-1,090.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$9.16 B-10,447.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-S$35.47 Million-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.28 B-1,550.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$86.31 M-197.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-S$30.04 Million-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA